Correlation Between Predictive Oncology and GlucoTrack

Can any of the company-specific risk be diversified away by investing in both Predictive Oncology and GlucoTrack at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Predictive Oncology and GlucoTrack into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Predictive Oncology and GlucoTrack, you can compare the effects of market volatilities on Predictive Oncology and GlucoTrack and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Predictive Oncology with a short position of GlucoTrack. Check out your portfolio center. Please also check ongoing floating volatility patterns of Predictive Oncology and GlucoTrack.

Diversification Opportunities for Predictive Oncology and GlucoTrack

0.6

Correlation Coefficient

Predictive Oncology  GlucoTrack

Poor diversification

The 3 months correlation between Predictive and GlucoTrack is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding Predictive Oncology and GlucoTrack in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GlucoTrack and Predictive Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Predictive Oncology are associated (or correlated) with GlucoTrack. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GlucoTrack has no effect on the direction of Predictive Oncology i.e., Predictive Oncology and GlucoTrack go up and down completely randomly.

Pair Corralation between Predictive Oncology and GlucoTrack

Given the investment horizon of 90 days Predictive Oncology is expected to under-perform the GlucoTrack. But the stock apears to be less risky and, when comparing its historical volatility, Predictive Oncology is 3.09 times less risky than GlucoTrack. The stock trades about -0.14 of its potential returns per unit of risk. The GlucoTrack is currently generating about -0.02 of returns per unit of risk over similar time horizon. If you would invest  1,014  in GlucoTrack on May 2, 2025 and sell it today you would lose (379.00) from holding GlucoTrack or give up 37.38% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	98.39%
Values	Daily Returns

Predictive Oncology  vs.  GlucoTrack

Predictive Oncology

Risk-Adjusted Performance

Very Weak

Over the last 90 days Predictive Oncology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in August 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

GlucoTrack

Risk-Adjusted Performance

Very Weak

Over the last 90 days GlucoTrack has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors.

Pair Trading with Predictive Oncology and GlucoTrack

The main advantage of trading using opposite Predictive Oncology and GlucoTrack positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Predictive Oncology position performs unexpectedly, GlucoTrack can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GlucoTrack will offset losses from the drop in GlucoTrack's long position.

The idea behind Predictive Oncology and GlucoTrack pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.